Cargando…
Short- to long-term follow-up of total femoral replacement in non-oncologic patients
BACKGROUND: Compromised bone stock and heavily impaired structural integrity after multiple endoprosthetic revision surgeries can lead to a comparable condition as encountered in musculoskeletal tumor surgery. Total femoral replacement (TFR) can restore femoral integrity and allow patients to resume...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154048/ https://www.ncbi.nlm.nih.gov/pubmed/27955655 http://dx.doi.org/10.1186/s12891-016-1355-6 |
_version_ | 1782474806245982208 |
---|---|
author | Toepfer, Andreas Harrasser, Norbert Petzschner, Isabel Pohlig, Florian Lenze, Ulrich Gerdesmeyer, Ludger Pförringer, Dominik Toepfer, Marcel Beirer, Marc Crönlein, Moritz von Eisenhart-Rothe, Ruediger Mühlhofer, Heinz |
author_facet | Toepfer, Andreas Harrasser, Norbert Petzschner, Isabel Pohlig, Florian Lenze, Ulrich Gerdesmeyer, Ludger Pförringer, Dominik Toepfer, Marcel Beirer, Marc Crönlein, Moritz von Eisenhart-Rothe, Ruediger Mühlhofer, Heinz |
author_sort | Toepfer, Andreas |
collection | PubMed |
description | BACKGROUND: Compromised bone stock and heavily impaired structural integrity after multiple endoprosthetic revision surgeries can lead to a comparable condition as encountered in musculoskeletal tumor surgery. Total femoral replacement (TFR) can restore femoral integrity and allow patients to resume ambulation. Even though several authors reported their results of TFR, so far many questions are still on debate: Which patients are at risk to experience low functional outcome? Do complications and clinical outcome after TFR depend on the indication for the surgery (e.g. periprosthetic fractures or aseptic loosening) or the age of the patients? The purpose of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients without malignant disease. METHODS: We conducted a retrospective chart review and functional investigation of patients treated with a TFR for non-oncologic conditions from 1995 to 2015 and a minimum follow-up of 2 years. Complications were recorded according to the Henderson-Classification; outcome was evaluated with established clinical scores. The indication for TFR was periprosthetic fracture (Group A, n = 11) or aseptic loosening (Group B, n = 7) with massive bone defect of the femur deemed unsuitable for conventional arthroplastic or biologic reconstruction. RESULTS: Eighteen patients matched the inclusion criteria and could be investigated clinically after a mean follow-up of 80 months (range: 28–132). Before TFA, all patients had previously undergone multiple operations (range: 1–8). The overall failure rate for any reason was 72% (n = 13/18), leading to a total of 37 surgical revisions with total exchange of TFR in 22% (n = 4/18). Most common failure mechanism was Type I (soft tissue), followed by Type IV (infection) and Type III (mechanical failure). According to Enneking’s functional evaluation method (MSTS-Score), the function ranged from 1 to 15 with a mean of 10 ± 4 out of 30. CONCLUSION: TFR is a salvage procedure to restore mechanical integrity and regain functional ability after extensive femoral bone loss. Outcome of the patients in the present study did mainly depend on the age at reconstruction and not on the indication for TFR. |
format | Online Article Text |
id | pubmed-5154048 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-51540482016-12-20 Short- to long-term follow-up of total femoral replacement in non-oncologic patients Toepfer, Andreas Harrasser, Norbert Petzschner, Isabel Pohlig, Florian Lenze, Ulrich Gerdesmeyer, Ludger Pförringer, Dominik Toepfer, Marcel Beirer, Marc Crönlein, Moritz von Eisenhart-Rothe, Ruediger Mühlhofer, Heinz BMC Musculoskelet Disord Research Article BACKGROUND: Compromised bone stock and heavily impaired structural integrity after multiple endoprosthetic revision surgeries can lead to a comparable condition as encountered in musculoskeletal tumor surgery. Total femoral replacement (TFR) can restore femoral integrity and allow patients to resume ambulation. Even though several authors reported their results of TFR, so far many questions are still on debate: Which patients are at risk to experience low functional outcome? Do complications and clinical outcome after TFR depend on the indication for the surgery (e.g. periprosthetic fractures or aseptic loosening) or the age of the patients? The purpose of the present study was to compare complication rates after TFR performed with modular total femur prosthesis MML (Fa. ESKA/Orthodynamics) in patients without malignant disease. METHODS: We conducted a retrospective chart review and functional investigation of patients treated with a TFR for non-oncologic conditions from 1995 to 2015 and a minimum follow-up of 2 years. Complications were recorded according to the Henderson-Classification; outcome was evaluated with established clinical scores. The indication for TFR was periprosthetic fracture (Group A, n = 11) or aseptic loosening (Group B, n = 7) with massive bone defect of the femur deemed unsuitable for conventional arthroplastic or biologic reconstruction. RESULTS: Eighteen patients matched the inclusion criteria and could be investigated clinically after a mean follow-up of 80 months (range: 28–132). Before TFA, all patients had previously undergone multiple operations (range: 1–8). The overall failure rate for any reason was 72% (n = 13/18), leading to a total of 37 surgical revisions with total exchange of TFR in 22% (n = 4/18). Most common failure mechanism was Type I (soft tissue), followed by Type IV (infection) and Type III (mechanical failure). According to Enneking’s functional evaluation method (MSTS-Score), the function ranged from 1 to 15 with a mean of 10 ± 4 out of 30. CONCLUSION: TFR is a salvage procedure to restore mechanical integrity and regain functional ability after extensive femoral bone loss. Outcome of the patients in the present study did mainly depend on the age at reconstruction and not on the indication for TFR. BioMed Central 2016-12-12 /pmc/articles/PMC5154048/ /pubmed/27955655 http://dx.doi.org/10.1186/s12891-016-1355-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Toepfer, Andreas Harrasser, Norbert Petzschner, Isabel Pohlig, Florian Lenze, Ulrich Gerdesmeyer, Ludger Pförringer, Dominik Toepfer, Marcel Beirer, Marc Crönlein, Moritz von Eisenhart-Rothe, Ruediger Mühlhofer, Heinz Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title | Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title_full | Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title_fullStr | Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title_full_unstemmed | Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title_short | Short- to long-term follow-up of total femoral replacement in non-oncologic patients |
title_sort | short- to long-term follow-up of total femoral replacement in non-oncologic patients |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154048/ https://www.ncbi.nlm.nih.gov/pubmed/27955655 http://dx.doi.org/10.1186/s12891-016-1355-6 |
work_keys_str_mv | AT toepferandreas shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT harrassernorbert shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT petzschnerisabel shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT pohligflorian shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT lenzeulrich shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT gerdesmeyerludger shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT pforringerdominik shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT toepfermarcel shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT beirermarc shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT cronleinmoritz shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT voneisenhartrotheruediger shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients AT muhlhoferheinz shorttolongtermfollowupoftotalfemoralreplacementinnononcologicpatients |